1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,880 | 3,140 | 23:00 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Aclarion's Nociscan technology used in back pain study | 2 | Investing.com | ||
| Mo | Aclarion, Inc.: Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study | 2 | GlobeNewswire (USA) | ||
| Do | Aclarion, Inc. Comments on Echo Lake Capital's Letter and Unsolicited Proposal | 64 | GlobeNewswire (Europe) | BROOMFIELD, Colo., May 28, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary... ► Artikel lesen | |
| Do | Echo Lake Capital Offers To Acquire Aclarion Inc. | 230 | ACCESS Newswire | Offers $4.00 per share in cash plus CVRStock currently trades below the value of its cash and other assetsBelieves company's public shell worth at least another $6 million if Board effected a reverse... ► Artikel lesen | |
| 13.05. | Aclarion, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 07.05. | Aclarion erweitert CLARITY-Studie um renommierte Privatpraxis für Wirbelsäulenchirurgie | 1 | Investing.com Deutsch | ||
| ACLARION Aktie jetzt für 0€ handeln | |||||
| 07.05. | Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial | 1 | Investing.com | ||
| 07.05. | Aclarion, Inc.: Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment | 1 | GlobeNewswire (USA) | ||
| 06.05. | Aclarion, Inc.: Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. | 1 | GlobeNewswire (USA) | ||
| 05.05. | Aclarion establishes second trial agreement with Weill Cornell | - | Investing.com | ||
| 05.05. | Aclarion schließt zweite Studienvereinbarung mit Weill Cornell ab | 4 | Investing.com Deutsch | ||
| 05.05. | Aclarion, Inc.: Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine | 1 | GlobeNewswire (USA) | ||
| 30.04. | Aclarion: Scanvolumen der Nociscan-Plattform steigt im ersten Quartal um 196 % | 5 | Investing.com Deutsch | ||
| 30.04. | Aclarion reports 196% jump in Nociscan scan volumes in Q1 | 5 | Investing.com | ||
| 30.04. | Aclarion, Inc.: Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption | 78 | GlobeNewswire (Europe) | Triple-digit annual growth signals accelerating Nociscan adoption and integration into clinical workflowsAdvancing reimbursement and clinical milestones, with CLARITY trial interim readout anticipated... ► Artikel lesen | |
| 28.04. | Aclarion, Inc.: Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan | 3 | GlobeNewswire (USA) | ||
| 22.04. | Aclarion authorizes $2.5 million share buyback program | 1 | Investing.com | ||
| 22.04. | Aclarion announces $2.5M stock repurchase plan | 1 | Seeking Alpha | ||
| 22.04. | Aclarion, Inc.: Aclarion Announces $2.5 Million Stock Repurchase Plan | 1 | GlobeNewswire (USA) | ||
| 22.04. | Aclarion, Inc. - 8-K, Current Report | - | SEC Filings |
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 324,60 | -0,61 % | ANALYSE: Unitedhealth: Der Kurs nähert sich einer gefährlichen Marke - Das sollten Sie jetzt wissen | ||
| INTUITIVE SURGICAL | 344,60 | -2,78 % | Intuitive Surgical, Inc.: Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton | SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the... ► Artikel lesen | |
| THERMO FISHER | 416,40 | -1,95 % | Laufende Fusionskontrollverfahren: Astorg Group S.à.r.l., Luxemburg; mittelbarer Erwerb alleiniger Kontrolle über den Mikrobiologie-Geschäftsbereich von Thermo Fisher Scientific Inc., Waltham/MA/USA (u.a. Oxoid Deutschland GmbH) | Datum der Anmeldung:22.05.2026Aktenzeichen:B3-68/26Unternehmen:Astorg Group S.à.r.l., Luxemburg; mittelbarer Erwerb alleiniger Kontrolle über den Mikrobiologie-Geschäftsbereich von Thermo Fisher Scientific... ► Artikel lesen | |
| TELADOC HEALTH | 6,594 | -2,97 % | TDOC Stock Pops as Teladoc Teams Up With Walmart | ||
| ROKU | 108,28 | -2,43 % | Aurzen Unveils the EAZZE D1R: The UK's First Roku TV Smart Projector for Effortless Big-Screen Streaming | LONDON, June 1, 2026 /PRNewswire/ -- Aurzen today announced the UK launch of the Aurzen Roku TV EAZZE D1R, the country's first smart projector powered by the Roku TV OS.Powered by the intuitive... ► Artikel lesen | |
| BAXTER | 15,650 | -1,11 % | Dividendenbekanntmachungen (29.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGNC INVESTMENT CORP US00123Q1040 0,12 USD 0,1029 EUR AGREE REALTY CORPORATION US0084921008 0,267 USD 0,2291 EUR ALLIED PROPERTIES... ► Artikel lesen | |
| INMODE | 11,500 | -1,63 % | InMode LTD: InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer | YOKNEAM, Israel, May 20, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company"), a leading global provider of innovative medical technologies... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 4,240 | -2,30 % | Atossa presents preclinical data on breast cancer drug at ASCO | ||
| DENTSPLY SIRONA | 8,552 | -0,79 % | Dentsply Sirona erweitert Vertriebspartnerschaft mit Nashville Dental | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| PETMED EXPRESS | 1,811 | -2,69 % | PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026 | ||
| CENTENE | 52,98 | -0,60 % | Centene Q1 Earnings Rise; Raises FY26 Guidance | WASHINGTON (dpa-AFX) - Centene Corp. (CNC), a for-profit healthcare company, on Tuesday reported higher net income in the first quarter of 2026 compared with the previous year despite a decline... ► Artikel lesen | |
| TANDEM DIABETES | 16,900 | +2,42 % | TNDM Stock: What to Know About Tandem's 2026 Reset | ||
| ORGANON | 11,445 | -0,48 % | Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia | SEOUL, South Korea, May 21, 2026 (GLOBE NEWSWIRE) -- Hanmi Pharmaceutical announced that it has signed a supply agreement with global healthcare company Organon to export three combination medicines... ► Artikel lesen | |
| FRESENIUS | 36,450 | +2,82 % | dpa-AFX-Überblick: UNTERNEHMEN vom 26.05.2026 - 15.15 Uhr | Schwerwiegende Bedenken: BP trennt sich von Verwaltungsratschef - Kursrutsch LONDON - Der britische Ölkonzern BP setzt seinen Verwaltungsratschef Albert Manifold wegen Vorwürfen vor die Tür. Als... ► Artikel lesen |
ACLARION INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 3,100 Euro und damit +18,32 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACLARION INC finden Sie auf Wallstreet Online.